• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Questions for Medicare in Meningitis Outbreak

Article

Medicare is coming under scrutiny in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply.

The giant health insurance program for seniors long ago flagged compounded drugs produced for the mass market without oversight from the Food and Drug Administration as safety risks. In 2007, Medicare revoked coverage of compounded inhaler drugs for lung disease.

Read the full story: http:/bit.ly/OQziq3

Source: The Associated Press

Related Videos
Ciara Zachary, PhD, MPH
William Schpero, PhD, MPhil, MPH
Jonathan Strober, MD, Benioff Children's Hospital
Adam Brufsky, MD, PhD
Ciara Zachary, PhD, MPH
Dr Xiaoxi Zhao
Oncology experts at PCOC
Dr Xiaoxi Zhao
UPMC Title Slide Open | Image Credit: © Notebook and Maggie Shaw
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.